Advertisements

Aminophylline

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Aminophylline

Property Description
Active ingredient Theophylline (via the Aminophylline complex)
Form Water-soluble complex (Injectable, Oral tablets, Suppositories)
Pharmacological class Bronchodilator, Methylxanthine
Common use Relief of airway constriction (bronchospasm)
Origin Synthetic

Defining Aminophylline: Class and Origin

Aminophylline is a specialized, synthetic medication that functions as a Bronchodilator, primarily indicated for opening and relaxing the air passages in the lungs. The compound is classified within the Methylxanthine drug group, which are substances derived from the natural purine base Xanthine. Its action as a Bronchodilator defines its core therapeutic goal. Unlike its less soluble parent compound, Aminophylline is clinically recognized for its efficiency in providing systemic relief from respiratory distress, positioning it as a primary medicine within its class.

Composition and Physical Form

Aminophylline is chemically defined as a water-soluble complex formed by the combination of Theophylline and Ethylenediamine in a precise two-to-one ratio. The core therapeutic molecule is Theophylline, which is poorly soluble on its own. Ethylenediamine is included specifically as a non-therapeutic component to improve the compound's stability and solubility, which is crucial for achieving therapeutic concentrations rapidly. This formulation is recognized for being adaptable to various delivery methods, ensuring it can be administered as oral tablets, suppositories, and solutions for injection. As a medicinal complex, its main action is to relax the bronchi and blood vessels.

General Purpose as a Bronchodilator

The general purpose of Aminophylline is to act as a smooth muscle relaxant to relieve the tightening of airways and restore normal respiratory function. This primary action facilitates the widening of the air passages and helps alleviate associated difficulty in breathing, particularly in the management of acute symptoms. This mechanism is effective in counteracting the constriction of the lungs’ airways.

Regulatory References

  1. The European Medicines Agency (EMA)
  2. FDA-Approved Drug Labeling for Aminophylline Injection, USP
Advertisements

What side effects are possible with Aminophylline?

Possible Side Effects and Safety Information

The safety profile of Aminophylline, which delivers the active drug Theophylline, is primarily defined by its narrow therapeutic index. This means the margin between an effective concentration and one that can cause toxicity is small, and the occurrence and severity of adverse reactions often directly correlate with elevated drug levels in the bloodstream.


Common Adverse Reactions and Affected Systems

Adverse effects are categorized by the system affected in official labeling. Reactions classified as common in regulatory documents typically involve the Gastrointestinal System (e.g., nausea and vomiting) and the Nervous System (e.g., headache, restlessness, and insomnia).


Serious Adverse Reactions

Serious adverse reactions, which are generally associated with toxic serum concentrations, are primarily neurological and cardiac events. These officially documented serious risks include seizures/convulsions and life-threatening cardiac arrhythmias, such as ventricular fibrillation. Regulatory notes specify that the risk of such severe effects is increased if the intravenous solution is administered too rapidly.


Population-Specific Safety Considerations

The official labeling outlines specific safety considerations for certain patient groups where drug clearance may be altered. Special caution and monitoring are documented for older adults and patients with hepatic (liver) impairment, as reduced drug metabolism in these populations can lead to accumulation and heightened risk of toxicity. Furthermore, Aminophylline is contraindicated in patients with known hypersensitivity to any Methylxanthine or ethylenediamine.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define Aminophylline overdose by its significant potential for CNS and Cardiovascular Toxicity, which requires immediate intervention. The primary molecule, Theophylline, is toxic when serum concentrations exceed 20 mcg/mL, though toxicity may occur at lower levels in specific populations.

Documented Overdose Manifestations

Symptoms officially documented in regulatory labeling often begin with persistent vomiting, nausea, headache, restlessness, and fine skeletal muscle tremors.

Overdose can rapidly escalate to potentially lethal intractable seizures, severe cardiac arrhythmias (such as ventricular tachycardia), cardiac arrest, and ultimately, death. Patients with hepatic cirrhosis, uncorrected acidemia, or those who are elderly or very young are noted to be at increased risk of severe toxicity.

Mandated Emergency Actions

Regulators explicitly require individuals to seek emergency medical help immediately if any signs of overdose occur, including persistent vomiting or an irregular heartbeat. In a clinical setting, an Aminophylline infusion must be stopped, and the serum theophylline concentration must be measured immediately.

Supportive Treatment

Management is strictly based on symptomatic and supportive treatment, as no specific antidote is documented in official labeling. Procedural measures listed include the administration of oral activated charcoal and continuous monitoring of vital signs and ECG (Electrocardiogram).

Advertisements

Therapeutic Uses of Aminophylline

Main Uses of Aminophylline

Aminophylline is a bronchodilator medication used to treat and prevent the symptoms of various obstructive airway diseases. It belongs to a class of drugs known as methylxanthines and works by relaxing the smooth muscles surrounding the airways in the lungs, which helps to open the air passages and facilitate easier breathing.

Chronic Obstructive Pulmonary Disease (COPD)

In the management of Chronic Obstructive Pulmonary Disease, including chronic bronchitis and emphysema, aminophylline is utilized to alleviate persistent respiratory symptoms. By reducing the resistance in the airways, the medication helps to manage chronic shortness of breath and improve overall airflow in patients with long-term lung impairment.

Asthma Management

Aminophylline is indicated for the treatment of asthma symptoms. It is often used as an add-on therapy for individuals whose symptoms are not sufficiently controlled by other medications. It helps to relieve the chest tightness, wheezing, and coughing associated with reversible airway obstruction.

Benefits and Physiological Effects

Beyond its primary role as a bronchodilator, aminophylline offers several physiological benefits that contribute to improved respiratory function:

  • Diaphragmatic Strengthening: Aminophylline has been shown to improve the contractility of the diaphragm, the primary muscle used for breathing. This can be particularly beneficial for patients with weakened respiratory muscles.
  • Mucociliary Clearance: The medication may assist in the clearance of mucus from the respiratory tract, helping to keep the airways clear.
  • Anti-inflammatory Properties: While not its primary mechanism, aminophylline possesses mild anti-inflammatory effects that can help reduce swelling in the airway linings.
  • Stimulation of the Respiratory Center: It acts as a mild central nervous system stimulant, which can help increase the drive to breathe in certain clinical settings.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Population Eligibility for Aminophylline

The use of Aminophylline, a xanthine derivative, is defined by strict regulatory criteria concerning age, concurrent health conditions, and clearance factors. The medicine is broadly approved for adults and children, including specialized use in infants for certain respiratory conditions, but requires careful monitoring in all populations.

Absolute Contraindications

Aminophylline is contraindicated and must not be used in patients with:

  • A known hypersensitivity to Theophylline, other xanthine compounds, or Ethylenediamine.
  • Concurrent therapy with other xanthine derivatives (risk of toxicity).
  • Acute porphyria.

Restricted and Conditional Use

Use requires caution or restriction in populations where drug clearance is reduced, which increases the risk of toxicity:

Population Group Eligibility Restriction (As Stated in Label)
Organ Impairment Hepatic impairment (cirrhosis, hepatitis) or congestive heart failure severely reduces clearance.
Age Groups Older adults (over 60 years) and infants under 6 months require careful dose consideration due to highly variable clearance.
Other Conditions Patients with active peptic ulcer disease, seizure disorders, hyperthyroidism, or specific cardiac arrhythmias must use with caution.
Pregnancy/Lactation Use during pregnancy is only if considered essential. Not recommended during lactation as Theophylline passes into breast milk.
Advertisements

What should I know about interactions with other medicines?

Official Interaction Restrictions

Co-administration of Aminophylline with other xanthine derivatives (e.g., pentoxifylline) is formally classified as contraindicated by regulatory authorities due to the documented risk of additive toxicity. Co-use with Ephedrine is specifically prohibited in children under 6 years of age. Separation of the oral dose from enteral (tube) feedings by one hour before and one hour after administration is required by regulatory documents to minimize interference with absorption.

Pharmacokinetic and Exposure Alterations

Official labeling describes numerous pharmacokinetic interactions that alter Theophylline's clearance. Substances documented to reduce clearance (increasing plasma concentration and exposure risk) include specific antibiotics (e.g., ciprofloxacin, macrolides), cimetidine, oral contraceptives, and certain cardiovascular agents (e.g., propranolol). Conversely, agents documented to increase clearance (decreasing plasma concentration) include Rifampicin and specific antiepileptics (e.g., phenytoin, phenobarbital).

Pharmacodynamic and Substance Interactions

Pharmacodynamic interactions include documented antagonism of Theophylline’s bronchodilator effects by beta-blockers. Other interactions, such as with sympathomimetics, carry a documented risk of additive CNS stimulation. Tobacco smoking increases Theophylline clearance, while smoking cessation reduces it, a critical factor in regulatory constraints. Consumption of large amounts of caffeine may also lead to additive CNS effects.

Population and Clearance Modifiers

Reduced clearance is officially documented in specific populations, including the elderly and individuals with conditions such as liver disease, congestive heart failure, or sustained fever. These factors inherently increase Theophylline exposure and must be considered in the context of any co-administered substance.

Advertisements

Mechanism of Action

️ How Aminophylline Works: Core Mechanisms

Aminophylline acts via its active ingredient, Theophylline, through two primary domains: enzymatic inhibition and receptor antagonism.

Enzyme Inhibition and Smooth Muscle Quiescence

The drug functions as a non-selective inhibitor of Phosphodiesterase (PDE) enzymes, notably PDE-III and PDE-IV, which are responsible for the hydrolysis of the cellular messenger cyclic AMP (cAMP). By increasing cAMP levels in the bronchial smooth muscle cells, this mechanism initiates a cascade that results in the relaxation of bronchial smooth muscle, a process known as smooth muscle quiescence.

Purinergic Receptor Blockade and Inflammatory Pathway Modulation

Theophylline also acts as a non-selective antagonist of Adenosine Receptors (A1, A2A, A2B), which prevents adenosine from activating its receptors, a signal that influences smooth muscle contraction and immune cell degranulation. Additionally, Theophylline can help restore the function of Histone Deacetylase 2 (HDAC2), an enzyme that suppresses the expression of pro-inflammatory genes, which contributes to the modulation of inflammatory gene transcription.

Advertisements

Dosage and Administration Information

How to use Aminophylline

Aminophylline is administered via different official methods and schedules, depending on whether the use is for acute management or long-term maintenance. All dosage must be carefully calculated using Ideal Body Weight (IBW).

Official Administration and Dosing Principles

Administration Route Standard Regimen Special Condition
Intravenous (IV) Initial loading dose (e.g., 5.7 mg/kg) infused slowly over 20 to 30 minutes, followed by a continuous maintenance infusion. The infusion rate must not exceed 25 mg/minute to comply with official guidelines.
Oral Divided doses (tablets or solution) typically administered every 6 to 8 hours for continuous therapeutic effect. Oral forms are generally taken with a full glass of water on an empty stomach (1 hour before or 2 hours after food).

Procedural and Population-Specific Rules

Official protocol requires strict therapeutic drug monitoring; the dose must be adjusted based on frequent measurements of the serum theophylline concentration, aiming for the documented therapeutic range.

  • Prior Therapy Check: The full loading dose must be adjusted or deferred if the patient has received any theophylline product in the preceding 24 hours.
  • Population Adjustment: Patients over 55, or those with cardiac or hepatic impairment, require a significantly reduced IV maintenance dose due to altered drug clearance.
  • Missed Dose: If an oral dose is missed, it should be taken as soon as remembered, unless it is close to the time of the next scheduled dose, in which case the missed dose is skipped (doses are not to be doubled).
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aminophylline

Evidence for Use in Acute Severe Airway Constriction

Research regarding Aminophylline's role in the management of severe, sudden airway tightening has primarily focused on short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies were studied for the medication's role in the research setting alongside standard emergency medications like inhaled bronchodilators and corticosteroids. Research examined outcomes related to key physiological measures, such as objective lung function tests (like FEV1), and critical outcomes, including a patient's need for subsequent intensive care or the length of time spent in the hospital.

Short-term trials monitored changes measured in symptoms in observed populations, particularly during the initial hours of treatment. Findings were mixed, with some studies describing patterns related to measured lung function when the medication was observed in addition to standard care. Systematic reviews highlighted measurements of hospitalization rates but noted that consistent observations related to these measurements were limited.


Evidence for Specialized Management of Apnea in Neonates

A distinct body of research, including RCTs and comparative meta-analyses, was observed in the context of Apnea of Prematurity in preterm infants. Studies research examined outcomes describing episodic or acute changes in breathing, specifically focusing on the frequency of periods where breathing pauses or a slow heart rate occurred. Research also describes what was measured regarding respiratory support during the study period.

Trials reported how symptoms evolved in preterm infants, with findings suggesting patterns related to the frequency of these respiratory events. Research has also explored measurements against other similar pharmacological agents, finding that patterns related to measured outcomes appear to be similar in some key respiratory areas.


What is Still Uncertain About Aminophylline Research

A key limitation across the research base is the inconsistent evidence quality and the mixed findings reported across studies. The data for certain groups remain insufficient, and the follow-up durations were limited for many indications, meaning long-term outcomes are not fully established. Researchers note that evidence from older trials appears to be less relevant to current clinical settings. This body of research highlights what is known—and what is still uncertain—about the medication's overall place in the evolving landscape of respiratory care.

Key Studies & References Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Aminophylline (FAQ)


Q: What is Aminophylline used for, besides asthma?

Regulatory documents state that Aminophylline is indicated for the symptomatic treatment of reversible bronchoconstriction associated with chronic conditions. This includes conditions such as COPD (Chronic Obstructive Pulmonary Disease), chronic bronchitis, and emphysema. Additionally, official documents mention its specialized use for certain forms of apnea in infants.


Q: Are there any foods or drinks I need to avoid while taking Aminophylline?

Official administration rules state that the oral forms are typically taken on an empty stomach (1 hour before or 2 hours after food). Consumption of large amounts of caffeine may lead to additive central nervous system (CNS) effects. Regulatory documents also caution against co-use with certain dietary supplements, such as St. John's wort, as this may reduce the medication's effectiveness.


Q: Is Aminophylline safe for older adults?

Official product information states that special caution and close monitoring are required for older adults (over 60 years). This is due to a documented age-related decrease in the body's ability to clear the drug, which increases the risk of drug accumulation and potential toxicity. A significantly reduced dose is often necessary in this population.


Q: Why do doctors use Aminophylline by injection sometimes?

The Intravenous (IV) form is used in a hospital setting for the acute management of sudden, severe airway constriction (bronchospasm) to rapidly establish the therapeutic drug concentration in the bloodstream. This method is reserved for urgent respiratory distress.


Q: Is there any research on Aminophylline use during pregnancy?

Official regulatory authorities state that use during pregnancy is only considered essential and the potential benefits are determined to outweigh the potential risks. The active drug (Theophylline) crosses the placental barrier. Additionally, use is generally not recommended during lactation because theophylline passes into breast milk.


Q: Do cold and flu medicines interact with Aminophylline?

Aminophylline has documented interactions with sympathomimetics, which is a class of drugs often found in certain cold and flu products, like decongestants. This combination carries a documented risk of additive CNS stimulation, which may result in increased heart rate or blood pressure.


Q: Can a person who has a history of heart issues take Aminophylline?

Regulatory documentation advises caution for patients with a history of heart issues, specifically naming congestive heart failure, specific cardiac arrhythmias, and severe hypertension. These conditions can be exacerbated by the drug's effects or lead to reduced drug clearance, increasing the risk of toxicity.


Q: How long does Aminophylline stay in your system?

The time the active drug (Theophylline) remains in the system can vary significantly among individuals. Regulatory guidance notes that the drug's half-life is documented to be approximately 4 hours in children (1–9 years) and around 8 hours in non-smoking adults.


Q: Does taking Aminophylline affect blood pressure?

Caution is advised for patients with severe hypertension (high blood pressure) according to regulatory guidelines. Theophylline can cause cardiovascular stimulation, and high dosages are associated with positive chronotropic (heart rate) and inotropic (force) effects.


Q: Is Aminophylline commonly prescribed for COPD?

Yes, regulatory documentation indicates that Aminophylline is a treatment option for the symptomatic relief of reversible airway constriction. This includes being used for conditions such as COPD (Chronic Obstructive Pulmonary Disease), chronic bronchitis, and emphysema.


Q: Can I take other asthma inhalers while using Aminophylline?

Aminophylline may interact with other respiratory medications. Official information notes the potential for antagonism of its bronchodilator effect by beta-blockers. There is also a risk of additive side effects when combined with sympathomimetics, a class of drugs often found in some inhalers.


Q: Why does Aminophylline sometimes cause nausea or stomach issues?

Official regulatory documents describe that the active drug, Theophylline, is known to stimulate gastric acid secretion and may also act as a local gastrointestinal irritant. This is the documented reason for common adverse effects such as nausea, vomiting, and epigastric pain.


Q: What is the difference between Aminophylline tablets and extended-release capsules?

The difference relates to the release mechanism of the drug. Regulatory documents describe sustained-release formulations (often labeled as extended-release) that are designed to produce a steady therapeutic blood level of theophylline over a longer period, typically 12 hours, unlike immediate-release forms.


Q: Are there different brand names for Aminophylline?

Yes, Aminophylline is the established generic or active ingredient name of the compound. However, the medicine has been marketed and sold under various brand names, such as Phyllocontin and Truphylline.


Q: Can Aminophylline cause anxiety or nervousness?

Yes, official adverse reaction reports classify nervousness, restlessness, and irritability as common reactions that affect the nervous system. These effects are often related to the stimulating properties of the methylxanthine drug class.


Q: Is Aminophylline available as a generic medicine?

Yes, the drug is widely available by its chemical name, Aminophylline, which is generally the generic form. Its use in various official products (e.g., Aminophylline Tablets BP) confirms its identity as a generic substance.


Q: What are the signs of a serious allergic reaction to Aminophylline?

Hypersensitivity reactions, often to the ethylenediamine component, are documented. Reported signs may include generalized rash, hives, or malaise. More severe signs noted in official documents can include exfoliative dermatitis and fever.


Q: Can I drink alcohol while on Aminophylline?

Official warnings specify that caution is advised for patients with chronic alcoholism. In this population, the clearance of Aminophylline may be decreased, which increases the risk of drug accumulation and toxicity.


Q: Is Aminophylline a steroid?

No, official classification documents state that Aminophylline is a Bronchodilator belonging to the Methylxanthine drug group. It is structurally related to caffeine and Theophylline, and is not classified as a corticosteroid (steroid).


Q: Are there any vitamins or supplements that interact with Aminophylline?

Yes, official sources caution that certain dietary supplements may interact with Aminophylline. Specifically, co-use with St. John's wort is noted as a caution in regulatory documents, as it is documented to potentially promote drug metabolism and reduce the medicinal effect of Aminophylline.


Q: Is it normal to feel a fast heartbeat after taking Aminophylline?

Possible adverse cardiac reactions documented in regulatory sources include palpitations (feeling a fast or fluttering heartbeat) and tachycardia (a fast heart rate). The risk of these effects, especially severe ones like cardiac arrhythmias, is often linked to elevated drug levels.


Q: Does Aminophylline affect kidney function?

Regulatory documents state that caution is needed for patients with impaired renal function (kidney dysfunction). This is because the clearance of theophylline can be significantly decreased in this population, which increases the risk of toxicity.


Q: Do different forms of Aminophylline (IV vs oral) have different side effects?

Official information notes that the risk of severe effects, such as seizures or cardiac arrhythmias, is documented to be increased if the intravenous solution is administered too rapidly. Clinical studies also suggest that common adverse reactions like nausea may be slightly more frequent with the IV form.


Q: Why is Aminophylline sometimes combined with other medications?

Combination use is documented for reasons such as achieving additive therapeutic effects or managing the risk of side effects that can arise from drug interactions. For example, it may be used alongside other bronchodilators to enhance the overall widening of the airways.


Q: Can over-the-counter heartburn medicine change how Aminophylline works?

Yes, certain acid-reducing medications like cimetidine are officially documented to reduce the clearance of theophylline, which can increase plasma concentration and toxicity risk. Separately, the drug itself is cautioned against in patients with peptic ulcer disease or GERD.

Advertisements

How should Aminophylline be stored and disposed of?

Storage and Disposal of Aminophylline

Official regulatory labeling dictates specific conditions for the storage and disposal of Aminophylline to ensure its stability.

Storage Requirements

Aminophylline must be stored at controlled room temperature, typically between 20 C and 25 C. It is crucial to protect the solution from freezing and also to protect it from light. The medication should be stored in its original container until use. As a mandatory safety measure, the product must always be kept out of the sight and reach of children.

Disposal Instructions

Any unused or expired Aminophylline product must be disposed of in accordance with local requirements for pharmaceutical waste. Regulatory guidance explicitly states that the medicine should not be disposed of via household waste or wastewater (e.g., flushing down the toilet or sink).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aminophylline found in:

A-Z Index: